Neurodegeneration in autoimmune CNS inflammation

Area of Science:

• Neuroimmunology
• Neurodegeneration
• Central Nervous System (CNS) Inflammation

Background:

• Multiple Sclerosis (MS) is traditionally viewed as a demyelinating disease targeting the myelin sheath.
• Emerging evidence highlights significant neurodegenerative processes, including axonal damage and neuronal death, occurring early in MS pathogenesis.
• Irreversible disability in MS correlates more strongly with neuronal damage than with demyelination.

Purpose of the Study:

• To review current understanding of inflammatory neurodegeneration in autoimmune CNS inflammation.
• To summarize recently identified molecular mechanisms driving neurodegeneration in MS.
• To elucidate the role of various immune cells in neuronal damage within the MS disease network.

Main Methods:

• Review of recent literature on Multiple Sclerosis (MS) and Experimental Autoimmune Encephalomyelitis (EAE) models.
• Analysis of findings from post-mortem MS biopsies.
• Synthesis of data on molecular mechanisms and immune cell involvement in neurodegeneration.

Main Results:

• Neurodegenerative features like axonal transection and neuronal death are present in early MS phases.
• Neuronal damage, rather than demyelination, is a stronger predictor of irreversible disability.
• Both demyelination-dependent and direct immune cell-mediated mechanisms are implicated in neuronal injury.

Conclusions:

• Inflammatory neurodegeneration is a critical component of MS pathogenesis.
• Understanding the complex interplay of immune cells and molecular mechanisms is crucial for addressing neuronal damage in MS.
• Further research into these pathways may reveal new therapeutic targets for mitigating MS-related disability.